Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies

por Odia, Yazmin, Cavalcante, Ludimila, Safran, Howard, Powell, Steven Francis, Munster, Pamela N, Ma, Wen Wee, Carneiro, Benedito A, Bastos, Bruno R, Mikrut, Stacy, Mikrut, William, Giles, Francis J, Sahebjam, Solmaz
Publicado 2022